GlobalRegenerative MedicineMarket was valued at US$ 29.1 billion in 2019 and is anticipated to reach US$ 178.6 billion by 2026 displaying reasonable CAGR of 31.5% over the forecast period (2020-2026).Regenerative Medicine refers to a group of biomedical approaches to clinical therapies that may involve the use of stem cells. The market of the Regenerative medicine market is anticipated to grow enormously owing to factors such as the growing prevalence of genetic disorders and chronic diseases, the rising pipeline of the regenerative medicine products, and technological advancements in the regenerative medicine field. Increasing the adoption of stem cell technologies, gene therapies, and tissue engineering for treating conditions such as blood cancer and other hematologic conditions is driving the industry growth
Recent Comments